Blueberry in the news again!

Blueberry’s CEO John Ridden was interviewed by Times writer Michael Cape.

John and Michael spoke about how Blueberry benefitted from AstraZeneca’s move to Cambridge, which led to husband and wife team David and Julie Cook (CSO and Principal Scientist) joining Blueberry in 2014.

Read the article here:

http://www.supernorth.co.uk/wp-content/uploads/2017/03/Super-North_170316-4.pdf

Julie Cook, one half of the husband and wife team, said “Although David and I both worked for AstraZeneca for a number of years, we have always worked in different departments. This is the first time we’ve worked closely together professionally. It’s great to be doing that in a small, exciting company”.

2018-02-13T12:31:32+00:00March 16th, 2017|Latest News|

Blueberry hold their first Site Initiation Visit in Berlin

The Blueberry Clinical Team, consisting of Dr Mike Davies, co-founder and Chief Medical Officer, Mark Sidaway, Clinical Project Manager and Jane Davies, Senior CRA, held their site initiation visit (SIV) at the Parexel Early Phase Clinical Unit in Berlin, Germany on Wednesday 8 March 2017.  This is in preparation for Blueberry’s first clinical trial with our novel, topical spray formulation of terbinafine to treat onychomycosis and associated tinea pedis.  This first trial of BB2603 will look at the safety, local toleration, systemic and local pharmacokinetics as well as efficacy in the chronic and frequently recurrent conditions of onychomycosis and tinea pedis.  Onychomycosis is currently treated with either oral antifungals (that have safety and systemic toleration issues), or topically applied antifungals and other medicines that show a very low efficacy.

The first trial of BB2603 is predicted to start in the coming weeks and will deliver primary and secondary endpoints, reading out mid 2017.

 

Experts examining how to take nail samples

Dr. med. Rainard Fuhr (Investigator) and Dr Tommaso Fadini (Co-Investigator) examine the nail sampling instrumentation

 

 

 

 

 

 

 

 

Experts reviewing the contents of Blueberry's allocated cupboard at Paraxel

Examining the contents of the Blueberry cupboard at the Parexel EPCU

 

 

 

 

 

 

 

 

Clinical Research nurse in the Blueberry clinic room for BB2603The Blueberry BB2603 clinic room

 

 

 

 

 

 

 

Team photo

Jane Davies (Snr CRA), Dr. med. Rainard Fuhr (Investigator), Mark Sidaway (CPM),  Dr Tommaso Fadini (Co-Investigator) and Sabine Klein-Haggerty (SCRC) at the […]

2018-02-13T12:31:32+00:00March 8th, 2017|Latest News|
Go to Top